Putting risk prediction in perspective: Relative utility curves

Journal of the National Cancer Institute

Volumn 101, Issue 22, 2009, Pages 1538-1542

  Baker, Stuart G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGE DISTRIBUTION; BREAST BIOPSY; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; DISEASE COURSE; FALSE POSITIVE RESULT; FAMILY HISTORY; GENOMICS; HIGH RISK POPULATION; HUMAN; NOTE; PREDICTION; PRIORITY JOURNAL; RACE; RECEIVER OPERATING CHARACTERISTIC; RISK BENEFIT ANALYSIS; RISK FACTOR;

BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MATHEMATICAL COMPUTING; MODELS, STATISTICAL; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 72949090243     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp353     Document Type: Note

References (15)

1. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008 ; 148 (5): 337-347.
2. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratifi cation tables. Ann Intern Med. 2008 ; 149 (10): 751-760.
3. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007 ; 115 (7): 928-935.
4. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978 ; 8 (4): 283-298.
5. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980 ; 302 (20): 1109-1117.
6. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical Decision Analysis. Philadelphia, PA: W.B. Saunders ; 1980.
7. Gail MH, Pfeiffer RM. On criteria for evaluating models of absolute risk. Biostatistics. 2005 ; 6 (2): 227-239.
8. Gail MH. Value of adding single-nucleotide polymorphism genotypes to breast cancer risk model. J Natl Cancer Inst. 2009 ; 101 (13): 959-963.
9. Baker SG, Cook NR, Vickers A, Kramer BS. Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A. 2009 ; 172 (4): 729-748.
10. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006 ; 26 (6): 565-574.
11. Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008 ; 8: 53.
12. Baker SG, Kramer BS. Peirce, Youden, and receiver operating characteristic curves. Am Stat. 2007 ; 61 (4): 343-346.
13. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 2005 ; 365 (9458): 488-492. (Pubitemid 40215731)
14. Baker SG. The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst. 2003 ; 9 (7): 511-515.
15. Dunkler D, Michiels S, Schemper M. Gene expression profi ling: does it add predictive accuracy to clinical characteristics in cancer prognosis? Eur J Cancer. 2007 ; 43 (4): 745-751